Funded Tech Companies
Neurovance
Neurovance, operating out of Cambridge, was acquired by Otsuka Pharmaceutical.
Company Overview
Company Name
Neurovance
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
43 Thorndike Street S1-3
Cambridge, MA 02141
USA
Cambridge, MA 02141
USA
Phone
Website
Email Address
Company Background Information
Overview
Neurovance is a clinical stage neuroscience-focused company. Following development of centanafadine SR (formerly EB-1020 SR) for adult ADHD, Neurovance will develop centanafadine SR for adolescent and pediatric ADHD.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/3/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anthony McKinney
Chief Financial Officer
Gregg Beloff
Chief Medical Officer
Ross Reife
VP - Finance
Vincent Pappafotopoulos
VP - Operations
Catherine O'Brien
Company Investors
- Novartis Venture Fund
- H&Q Asia/Pacific
- Venture Investors
- GBS Venture Partners
- State of Wisconsin Investment Board
Browse more funded tech companies:
NeuroTronik | NeuroVasc Technologies
Share this article
About Our VC Deals Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs